title: Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation.
abstract: Allogeneic bone marrow transplantation (BMT) is the therapy of choice for a variety of malignant and nonmalignant disorders; however, a major constraint to successful BMT is graft versus host disease (GVHD). Skin lesions are the earliest presentation of GVHD. Donor-derived cytotoxic T lymphocytes are the effector cells responsible for lesions in the skin and other tissues. Here we show that most skin-infiltrating lymphocytes, in all forms of GVHD, are memory T cells with a predominance of CD4+ cells in the dermis and CD8+ cells in the epidermis. Relatively little attention has been focused on the adhesive phenotype of keratinocytes in GVHD. In this study, immunohistochemical analyses of skin biopsies from BMT patients with acute or chronic GVHD were conducted, with particular emphasis on antigen-presenting cells (APCs) and on keratinocytes. The distribution of APCs in the epidermis (Langerhans' cells) was investigated. Keratinocytes were analyzed for the expression of human leukocyte antigen DR locus (HLA-DR) and of a novel integrin, alpha10.1.2 beta1, which is detected in the basal layer of normal epidermis. Langerhans' cells were decreased in all grades of acute GVHD, but the epidermal APC network was reconstituted in chronic GVHD. HLA-DR was expressed by keratinocytes in grade 2 and 3 acute GVHD lesions, but not in two of three chronic GVHD cases, and in the regression phase of acute GVHD. Integrin chains alpha10.1.2 and beta1 were detected in the epidermal basal cell layer of most GVHD cases but they were also expressed in suprabasal keratinocytes of both acute and chronic GVHD. This latter finding indicates that a proliferative response uncoupled from differentiation occurs in keratinocytes in the course of GVHD.
authors.affiliation: Department of Anatomy, University of Genoa, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Favre
authors.forename: A
authors.initials: A
authors.lastname: Cerri
authors.forename: A
authors.initials: A
authors.lastname: Bacigalupo
authors.forename: E
authors.initials: E
authors.lastname: Lanino
authors.forename: E
authors.initials: E
authors.lastname: Berti
authors.forename: C E
authors.initials: CE
authors.lastname: Grossi
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000938:Antigen-Presenting Cells / Q000473:pathology; D015703:Antigens, CD / Q000032:analysis; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D002908:Chronic Disease; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology / Q000473:pathology*; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D016023:Integrins / Q000032:analysis; D008297:Male; D012871:Skin Diseases / Q000209:etiology / Q000473:pathology*
chemical_list: D015703:Antigens, CD; D006680:HLA Antigens; D016023:Integrins